[1] JEMAL A, SIEGEL R, XU J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5):277-300. [2] BROCKLEHURST P R, BAKER S R, SPEIGHT P M. Oral cancer screening:what have we learnt and what is there still to achieve?[J]. Future Oncol, 2010, 6(2):299-304. [3] 夏辉, 李龙江. 口腔鳞癌术后复发相关因素的临床研究[J]. 实用口腔医学杂志, 2007,23(2):276-279. [4] WHITE E J, MATSANGOS A E, WILSON G M. AUF1 regulation of coding and noncoding RNA[J]. Wiley Interdiscip Rev RNA, 2017, 8(2):e1393. [5] MOORE A E, CHENETTE D M, LARKIN L C, et al. Physiological networks and disease functions of RNA-binding protein AUF1[J]. Wiley Interdiscip Rev RNA, 2014,5(4):549-564. [6] SCHNELL U, CIRULLI V, GIEPMANS B N. EpCAM:structure and function in health and disease[J]. Biochim Biophys Acta,2013, 1828(8):1989-2001. [7] BLAXALL B C, DWYER-NIELD L D, BAUER A K, et al. Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue[J]. Mol Carcinog, 2000, 28(2):76-83. [8] TROJANOWICZ B, BRODAUF L, SEKULLA C, et al. Stability of mRNA and carcinogenesis:The role of AUF1 in thyroid carcinoma progression[J]. Exp Clin Endocr Diabet, 2007, 115(Suppl 1).DOI:10.1055/S-2007-972359. [9] 耿杨杨,张露露,徐苗苗,等. hnRNPD在食管鳞状细胞癌的表达及意义[J]. 细胞与分子免疫学杂志, 2015,31(12):1659-1663. [10] BREWER G, SACCANI S, SARKAR S, et al. Increased interleukin-10 mRNA stability in melanoma cells is associated with decreased levels of A+ U-rich element binding factor AUF1[J]. J Interferon Cytokine Res, 2003, 23(10):553-564. [11] FELLOWS A, GRIFFIN M E, PETRELLA B L, et al. AUF1/hnRNP D represses expression of VEGF in macrophages[J]. Mol Biol Cell, 2012, 23(8):1414-1422. [12] SPIZZO G, FONG D, WURM M, et al. EpCAM expression in primary tumour tissues and metastases:an immunohistochemical analysis[J]. J Clin Pathol, 2011, 64(5):415-420. [13] ZHENG X H, FAN X L, FU B Q, et al. EpCAM inhibition sensitizes chemoresistant leukemia to immune surveillance[J]. Cancer Res, 2017, 77(2):482-493. [14] SOMASUNDARAM R T, KAUR J, LEONG I, et al. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis[J]. BMC Cancer, 2016, 16(1):486. [15] CIMINO A, HALUSHKA M, ILLEI P, et al. Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases[J]. Breast Cancer Res Treat, 2010, 123(3):701-708. [16] LEE S J, CHUNG K Y, KWON J E, et al. Expression of EpCAM in adenoid cystic carcinoma[J]. Pathology, 2018, 50(7):737-741. [17] YAHYAZADEH MAS HHADI S M, KAZEMIMANESH M, ARASHKIA A, et al. Shedding light on the EpCAM:an overview[J]. J Cell Physiol, 2019, 234(8):12569-12580. [18] PATHAK S J, MUELLER J L, OKAMOTO K, et al. EPCAM mutation update:Variants associated with congenital tufting enteropathy and Lynch syndrome[J]. Hum Mutat, 2019, 40(2):142-161. [19] WANGSA D, CHOWDHURY S A, RYOTT M, et al. Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis[J]. Int J Cancer, 2016, 138(1):98-109. [20] KUMAR M, MATTA A, MASUI O, et al. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer[J]. J Transl Med, 2015, 13:285. [21] ZHANG S T, WU X, DIAO P F, et al. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma[J]. J Cell Physiol, 2020,235(5):4804-4813. [22] SEN S, CARNELIO S. Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma[J]. Histopathology, 2016, 68(6):897-904. [23] LAIMER K, FONG D, GASTL G, et al. EpCAM expression in squamous cell carcinoma of the oral cavity:frequency and relationship to clinicopathologic features[J]. Oral Oncol, 2008, 44(1):72-77. [24] HAYRY V, KAGEDAL A, HJALMARSSON E, et al. Rapid nodal staging of head and neck cancer surgical specimens with flow cytometric analysis[J]. Br J Cancer, 2018, 118(3):421-427. [25] LV M, ZHONG Z Y, HUANG M G, et al. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA[J]. Biochim Biophys Acta Mol Cell Res, 2017, 1864(10):1887-1899. [26] 夏丽,李冰.姜黄素在抗口腔黏膜下纤维化中的作用研究进展[J].解放军医学杂志,2019,44(4):357-360. |